Literature DB >> 18203153

Phacomatosis cesioflammea with unilateral lipohypoplasia.

Marco Castori1, Rosanna Rinaldi, Corrado Angelo, Giovanna Zambruno, Paola Grammatico, Rudolf Happle.   

Abstract

Phacomatosis cesioflammea is characterized by the co-existence of a large nevus cesius (i.e., aberrant Mongolian spot, or nevus fuscocoeruleus) and an extensive nevus flammeus (i.e., port-wine stain). This sporadic genetic skin disorder represents a particular type of phacomatosis pigmentovascularis, a group of disorders that may reflect twin spotting. We report on a 28-year-old woman with aberrant Mongolian spots, bilateral melanosis bulbi, and systematized nevus flammeus partly intermingled with nevus anemicus. Moreover, pronounced lipohypoplasia of the right buttock and thigh as well as hypoplasia of the right breast are present. This anomaly of fatty tissue has not previously been reported in phacomatosis cesioflammea and further expands the clinical spectrum of this mosaic disorder. The patchy distribution of lipohypoplasia and its spatial relationship with vascular lesions strongly support the hypothesis of a postzygotic recombination event.

Entities:  

Mesh:

Year:  2008        PMID: 18203153     DOI: 10.1002/ajmg.a.32165

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  2 in total

Review 1.  Extracutaneous manifestations in phacomatosis cesioflammea and cesiomarmorata: Case series and literature review.

Authors:  Akash Kumar; Diane B Zastrow; Elijah J Kravets; Daniah Beleford; Maura R Z Ruzhnikov; Megan E Grove; Annika M Dries; Jennefer N Kohler; Daryl M Waggott; Yaping Yang; Yong Huang; Katherine M Mackenzie; Christine M Eng; Paul G Fisher; Euan A Ashley; Joyce M Teng; David A Stevenson; Joseph T Shieh; Matthew T Wheeler; Jonathan A Bernstein
Journal:  Am J Med Genet A       Date:  2019-03-28       Impact factor: 2.802

2.  Phacomatosis pigmentovascularis of cesioflammea type.

Authors:  Delky Johanna Villarreal Villarreal; Fabiano Leal
Journal:  An Bras Dermatol       Date:  2016 Sep-Oct       Impact factor: 1.896

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.